Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China flag China · Delayed Price · Currency is CNY
17.12
+0.37 (2.21%)
May 16, 2025, 3:04 PM CST

Hubei Goto Biopharm Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2017 - 2019
Cash & Equivalents
141.18181.97438.42209.9128.96
Upgrade
Trading Asset Securities
0015.010.1-
Upgrade
Cash & Short-Term Investments
141.18181.97453.43210.0228.96
Upgrade
Cash Growth
-22.42%-59.87%115.90%625.10%-77.66%
Upgrade
Accounts Receivable
214.26235.4269.36243.86312.53
Upgrade
Other Receivables
2.052.151.882.090.72
Upgrade
Receivables
216.31237.54271.25245.95313.26
Upgrade
Inventory
384.8396.16432.5371.24200.74
Upgrade
Prepaid Expenses
---1.681.27
Upgrade
Other Current Assets
27.754.0656.5629.3735.42
Upgrade
Total Current Assets
770869.731,214858.26579.64
Upgrade
Property, Plant & Equipment
1,8491,391610.94256.57198.11
Upgrade
Long-Term Investments
48.2748.2448.0814.47-
Upgrade
Other Intangible Assets
49.885143.1427.8221.06
Upgrade
Long-Term Deferred Tax Assets
37.2922.6217.898.823.43
Upgrade
Long-Term Deferred Charges
9.6213.313.960.971.93
Upgrade
Other Long-Term Assets
25.8551.96121.5644.340.26
Upgrade
Total Assets
2,7902,4482,0691,211804.43
Upgrade
Accounts Payable
459.91532.24205.52138.1774.12
Upgrade
Accrued Expenses
9.519.259.587.516.4
Upgrade
Short-Term Debt
294.3110.09321.63143.41118
Upgrade
Current Portion of Long-Term Debt
24.6122.275.24--
Upgrade
Current Portion of Leases
-0.451.9811.4721.77
Upgrade
Current Income Taxes Payable
2.842.87.2111.275.73
Upgrade
Current Unearned Revenue
1.233.472.013.70.19
Upgrade
Other Current Liabilities
15.285.8422.7917.6520.92
Upgrade
Total Current Liabilities
807.69686.41575.97333.18247.13
Upgrade
Long-Term Debt
812.64652.37437.04--
Upgrade
Long-Term Leases
-0.544.416.679.75
Upgrade
Long-Term Unearned Revenue
150.2584.3369.7142.987.69
Upgrade
Long-Term Deferred Tax Liabilities
0.010.290.970-
Upgrade
Other Long-Term Liabilities
4.650.030.05-0.02
Upgrade
Total Liabilities
1,7751,4241,088382.83264.58
Upgrade
Common Stock
115.28115.28115.28115.2886.28
Upgrade
Additional Paid-In Capital
410.6410.77409.11409.11243.92
Upgrade
Retained Earnings
300.77330.2307.2282.67204.34
Upgrade
Comprehensive Income & Other
96.4996.4996.51--
Upgrade
Total Common Equity
923.14952.75928.09807.05534.54
Upgrade
Minority Interest
91.571.0353.0721.365.31
Upgrade
Shareholders' Equity
1,0151,024981.16828.42539.85
Upgrade
Total Liabilities & Equity
2,7902,4482,0691,211804.43
Upgrade
Total Debt
1,132785.73770.3161.54149.51
Upgrade
Net Cash (Debt)
-990.37-603.75-316.8748.47-120.55
Upgrade
Net Cash Per Share
-8.61-5.25-2.760.46-1.40
Upgrade
Filing Date Shares Outstanding
105.8115.28115.28115.28115.28
Upgrade
Total Common Shares Outstanding
105.8115.28115.28115.2886.28
Upgrade
Working Capital
-37.69183.33637.76525.08332.52
Upgrade
Book Value Per Share
8.738.268.057.006.20
Upgrade
Tangible Book Value
873.26901.75884.95779.23513.48
Upgrade
Tangible Book Value Per Share
8.257.827.686.765.95
Upgrade
Buildings
-129.73108.6795.5391.93
Upgrade
Machinery
-207.89196.16180.78175.11
Upgrade
Construction In Progress
-1,182411.9966.385.3
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.